Huma and UCB partner to provide technology solution to help manage Myasthenia gravis
Huma Therapeutics (“Huma”), a leading global digital health company, and UCB, a global biopharmaceutical company, are partnering to offer a digital technology solution to help patients with the rare disease, Myasthenia gravis (MG), better understand and manage their condition with the support of their clinician. The digital platform is launching in Europe ahead of international expansion. The […]
